These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 25457653

  • 1. Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates.
    Ghosh SC, Pinkston KL, Robinson H, Harvey BR, Wilganowski N, Gore K, Sevick-Muraca EM, Azhdarinia A.
    Nucl Med Biol; 2015 Feb; 42(2):177-83. PubMed ID: 25457653
    [Abstract] [Full Text] [Related]

  • 2. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M, Madsen J, Østergaard S, Ploug M, Kjaer A.
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [Abstract] [Full Text] [Related]

  • 3. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.
    Fani M, Del Pozzo L, Abiraj K, Mansi R, Tamma ML, Cescato R, Waser B, Weber WA, Reubi JC, Maecke HR.
    J Nucl Med; 2011 Jul; 52(7):1110-8. PubMed ID: 21680701
    [Abstract] [Full Text] [Related]

  • 4. Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody.
    Dearling JL, Voss SD, Dunning P, Snay E, Fahey F, Smith SV, Huston JS, Meares CF, Treves ST, Packard AB.
    Nucl Med Biol; 2011 Jan; 38(1):29-38. PubMed ID: 21220127
    [Abstract] [Full Text] [Related]

  • 5. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.
    Hall MA, Pinkston KL, Wilganowski N, Robinson H, Ghosh P, Azhdarinia A, Vazquez-Arreguin K, Kolonin AM, Harvey BR, Sevick-Muraca EM.
    J Nucl Med; 2012 Sep; 53(9):1427-37. PubMed ID: 22872743
    [Abstract] [Full Text] [Related]

  • 6. Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu-An EGFR-Targeted Theranostic for Pancreatic Cancer.
    Aghevlian S, Lu Y, Winnik MA, Hedley DW, Reilly RM.
    Mol Pharm; 2018 Mar 05; 15(3):1150-1159. PubMed ID: 29314858
    [Abstract] [Full Text] [Related]

  • 7. Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts.
    Malmberg J, Perols A, Varasteh Z, Altai M, Braun A, Sandström M, Garske U, Tolmachev V, Orlova A, Karlström AE.
    Eur J Nucl Med Mol Imaging; 2012 Mar 05; 39(3):481-92. PubMed ID: 22322933
    [Abstract] [Full Text] [Related]

  • 8. Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with 111In using a maleimido derivative of NODAGA.
    Altai M, Perols A, Karlström AE, Sandström M, Boschetti F, Orlova A, Tolmachev V.
    Nucl Med Biol; 2012 May 05; 39(4):518-29. PubMed ID: 22172396
    [Abstract] [Full Text] [Related]

  • 9. MANOTA: a promising bifunctional chelating agent for copper-64 immunoPET.
    Moreau M, Poty S, Vrigneaud JM, Walker P, Guillemin M, Raguin O, Oudot A, Bernhard C, Goze C, Boschetti F, Collin B, Brunotte F, Denat F.
    Dalton Trans; 2017 Oct 31; 46(42):14659-14668. PubMed ID: 28861553
    [Abstract] [Full Text] [Related]

  • 10. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
    Oxboel J, Brandt-Larsen M, Schjoeth-Eskesen C, Myschetzky R, El-Ali HH, Madsen J, Kjaer A.
    Nucl Med Biol; 2014 Mar 31; 41(3):259-67. PubMed ID: 24417983
    [Abstract] [Full Text] [Related]

  • 11. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
    Lewis MR, Wang M, Axworthy DB, Theodore LJ, Mallet RW, Fritzberg AR, Welch MJ, Anderson CJ.
    J Nucl Med; 2003 Aug 31; 44(8):1284-92. PubMed ID: 12902420
    [Abstract] [Full Text] [Related]

  • 12. Improved Conjugation, 64-Cu Radiolabeling, in Vivo Stability, and Imaging Using Nonprotected Bifunctional Macrocyclic Ligands: Bis(Phosphinate) Cyclam (BPC) Chelators.
    David T, Hlinová V, Kubíček V, Bergmann R, Striese F, Berndt N, Szöllősi D, Kovács T, Máthé D, Bachmann M, Pietzsch HJ, Hermann P.
    J Med Chem; 2018 Oct 11; 61(19):8774-8796. PubMed ID: 30180567
    [Abstract] [Full Text] [Related]

  • 13. PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates.
    Beaino W, Anderson CJ.
    J Nucl Med; 2014 Nov 11; 55(11):1856-63. PubMed ID: 25256059
    [Abstract] [Full Text] [Related]

  • 14.
    Chopra A.
    ; 2004 Nov 11. PubMed ID: 23586111
    [Abstract] [Full Text] [Related]

  • 15. Influence of nuclides and chelators on imaging using affibody molecules: comparative evaluation of recombinant affibody molecules site-specifically labeled with ⁶⁸Ga and ¹¹¹In via maleimido derivatives of DOTA and NODAGA.
    Altai M, Strand J, Rosik D, Selvaraju RK, Eriksson Karlström A, Orlova A, Tolmachev V.
    Bioconjug Chem; 2013 Jun 19; 24(6):1102-9. PubMed ID: 23705574
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of radiolabeled bombesin analogs for the PET imaging of prostate cancer.
    Liu Y, Hu X, Liu H, Bu L, Ma X, Cheng K, Li J, Tian M, Zhang H, Cheng Z.
    J Nucl Med; 2013 Dec 19; 54(12):2132-8. PubMed ID: 24198391
    [Abstract] [Full Text] [Related]

  • 17. Biological stability evaluation of the α2β1 receptor imaging agents: diamsar and DOTA conjugated DGEA peptide.
    Huang CW, Li Z, Cai H, Shahinian T, Conti PS.
    Bioconjug Chem; 2011 Feb 16; 22(2):256-63. PubMed ID: 21244039
    [Abstract] [Full Text] [Related]

  • 18. The ionic charge of copper-64 complexes conjugated to an engineered antibody affects biodistribution.
    Dearling JL, Paterson BM, Akurathi V, Betanzos-Lara S, Treves ST, Voss SD, White JM, Huston JS, Smith SV, Donnelly PS, Packard AB.
    Bioconjug Chem; 2015 Apr 15; 26(4):707-17. PubMed ID: 25719414
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and In Vitro Comparison of DOTA, NODAGA and 15-5 Macrocycles as Chelators for the 64Cu-Labelling of Immunoconjugates.
    Maisonial-Besset A, Witkowski T, Quintana M, Besse S, Gaumet V, Cordonnier A, Alliot C, Vidal A, Denevault-Sabourin C, Tarrit S, Levesque S, Miot-Noirault E, Chezal JM.
    Molecules; 2022 Dec 22; 28(1):. PubMed ID: 36615280
    [Abstract] [Full Text] [Related]

  • 20. The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model.
    Rylova SN, Stoykow C, Del Pozzo L, Abiraj K, Tamma ML, Kiefer Y, Fani M, Maecke HR.
    PLoS One; 2018 Dec 22; 13(4):e0195802. PubMed ID: 29668724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.